| Primary |
| Product Used For Unknown Indication |
17.2% |
| Dyspepsia |
10.2% |
| Antacid Therapy |
6.3% |
| Blood Cholesterol |
6.3% |
| Cardiac Disorder |
6.3% |
| Anxiety |
5.5% |
| Cystic Fibrosis |
5.5% |
| Pancreatitis |
5.5% |
| Medical Diet |
4.7% |
| Blood Pressure |
3.9% |
| Hypertension |
3.9% |
| Pain |
3.9% |
| Pancreatic Carcinoma |
3.1% |
| Pancreatic Insufficiency |
3.1% |
| Pancreatitis Chronic |
3.1% |
| Pancreatitis Relapsing |
3.1% |
| Prophylaxis |
3.1% |
| Irritable Bowel Syndrome |
2.3% |
| Abdominal Discomfort |
1.6% |
| Blood Glucose Increased |
1.6% |
|
| Product Quality Issue |
9.4% |
| Weight Decreased |
9.4% |
| Abdominal Pain Upper |
6.3% |
| Hospitalisation |
6.3% |
| Overgrowth Bacterial |
6.3% |
| Pain |
6.3% |
| Post Gastric Surgery Syndrome |
6.3% |
| Product Container Issue |
6.3% |
| Vomiting |
6.3% |
| Weight Increased |
6.3% |
| Arthralgia |
3.1% |
| Aspiration |
3.1% |
| Cardiac Operation |
3.1% |
| Cerebrovascular Accident |
3.1% |
| Cholecystectomy |
3.1% |
| Coeliac Disease |
3.1% |
| Concussion |
3.1% |
| Constipation |
3.1% |
| Diabetes Mellitus |
3.1% |
| Drug Dose Omission |
3.1% |
|
| Secondary |
| Dyspepsia |
13.3% |
| Product Used For Unknown Indication |
11.4% |
| Pancreatitis Relapsing |
10.1% |
| Antacid Therapy |
8.2% |
| Blood Cholesterol |
7.6% |
| Anxiety |
7.0% |
| Hypertension |
6.3% |
| Medical Diet |
6.3% |
| Abdominal Discomfort |
5.1% |
| Gastritis |
5.1% |
| Pancreatitis |
5.1% |
| Pancreatitis Chronic |
5.1% |
| Pancreatic Carcinoma |
2.5% |
| Neoplasm Malignant |
1.3% |
| Nutritional Supplementation |
1.3% |
| Pancreaticoduodenectomy |
1.3% |
| Whipple's Disease |
1.3% |
| Abnormal Faeces |
0.6% |
| Antasthmatic Drug Level |
0.6% |
| Antiinflammatory Therapy |
0.6% |
|
| Pancreatitis Acute |
12.1% |
| Skin Wrinkling |
12.1% |
| Abdominal Pain Upper |
9.1% |
| Product Quality Issue |
9.1% |
| Arthralgia |
6.1% |
| Expired Drug Administered |
6.1% |
| Flatulence |
6.1% |
| Hospitalisation |
6.1% |
| Neoplasm Malignant |
6.1% |
| Pain |
6.1% |
| Product Container Issue |
6.1% |
| Abnormal Loss Of Weight |
3.0% |
| Cardiac Failure |
3.0% |
| Diabetes Mellitus |
3.0% |
| Drug Level Below Therapeutic |
3.0% |
| Heart Rate Decreased |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.7% |
| Prophylaxis |
10.4% |
| Hypertension |
9.5% |
| Hepatitis C |
5.3% |
| Asthenopia |
4.8% |
| Diabetes Mellitus |
4.6% |
| Pancreatic Neuroendocrine Tumour |
3.9% |
| Type 2 Diabetes Mellitus |
3.9% |
| Constipation |
3.7% |
| Gastritis |
3.4% |
| Pain |
3.2% |
| Depression |
2.9% |
| Insomnia |
2.9% |
| Cancer Pain |
2.2% |
| Dyspepsia |
2.2% |
| Gastric Cancer |
2.2% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Abdominal Discomfort |
2.0% |
| Cholelithiasis |
2.0% |
| Colorectal Cancer |
2.0% |
|
| Haemoglobin Decreased |
10.4% |
| Ligament Rupture |
10.4% |
| Duodenal Ulcer |
7.5% |
| Liver Disorder |
7.5% |
| Hepatitis Fulminant |
6.0% |
| Back Pain |
4.5% |
| Cardiac Failure |
4.5% |
| Drowning |
4.5% |
| Glossitis |
4.5% |
| Hepatitis B |
4.5% |
| Suicide Attempt |
4.5% |
| Thrombocytopenia |
4.5% |
| Weight Increased |
4.5% |
| White Blood Cell Count Decreased |
4.5% |
| Altered State Of Consciousness |
3.0% |
| Aplasia Pure Red Cell |
3.0% |
| Blood Albumin Decreased |
3.0% |
| Hiccups |
3.0% |
| Interstitial Lung Disease |
3.0% |
| Jaundice |
3.0% |
|
